TITAN PHARMACEUTICALS INC DE's ticker is TTNP and the CUSIP is 888314606. A total of 28 filers reported holding TITAN PHARMACEUTICALS INC DE in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $40 | -25.9% | 84 | +1.2% | 0.00% | – |
| Q2 2023 | $54 | -16.9% | 83 | +6.4% | 0.00% | – |
| Q1 2023 | $65 | +8.3% | 78 | +1.3% | 0.00% | – |
| Q4 2022 | $60 | – | 77 | +2.7% | 0.00% | – |
| Q3 2022 | $0 | – | 75 | -7.4% | 0.00% | – |
| Q2 2022 | $0 | – | 81 | +19.1% | 0.00% | – |
| Q1 2022 | $0 | – | 68 | +13.3% | 0.00% | – |
| Q4 2021 | $0 | – | 60 | 0.0% | 0.00% | – |
| Q3 2021 | $0 | – | 60 | +30.4% | 0.00% | – |
| Q2 2021 | $0 | – | 46 | 0.0% | 0.00% | – |
| Q1 2021 | $0 | – | 46 | +2.2% | 0.00% | – |
| Q4 2020 | $0 | – | 45 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 863,512 | $826,000 | 0.02% |
| Level Financial Advisors | 987 | $1,000 | 0.00% |
| Westside Investment Management, Inc. | 4 | $0 | 0.00% |
| Fortitude Advisory Group L.L.C. | 8 | $0 | 0.00% |
| American Portfolios Advisors | 23 | $22 | 0.00% |
| Renaissance Technologies | 36,510 | $35,000 | 0.00% |
| BARCLAYS PLC | 50,050 | $48,000 | 0.00% |
| VANGUARD GROUP INC | 206,428 | $197,000 | 0.00% |
| UBS Group AG | 7,123 | $7,000 | 0.00% |
| IFP Advisors, Inc | 844 | $3,000 | 0.00% |